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Treated With Bioresorbable
Everolimus-Eluting Stent V-Stenting
Katsumasa Sato, MD,* Azeem Latib, MD,* Vasileios F. Panoulas, MD, MRCP, PHD,*y Toru Naganuma, MD,*
Tadashi Miyazaki, MD,* Antonio Colombo, MD*T his is the ﬁrst case in the literature describingthe V-stenting technique using ABSORB(Abbott Vascular, Santa Clara, California) bio-
resorbable everolimus-eluting scaffolds (BVS) for the
treatment of a left main coronary artery (LMCA) true
bifurcation lesion. A 66-year-old woman presented
with symptoms of stable angina. A diagnostic angio-
gram revealed a signiﬁcant mid-left anterior descend-
ing artery (LAD) lesion. After successful implantation
of 2 BVS in the mid-LAD, a control angiogram
showed haziness extending from distal LMCA into
LAD ostium (Medina 0.1.1), likely representing plaqueFrom the *Interventional Cardiology Unit, EMO-GVM Centro Cuore Columb
Institute, Imperial College, London, United Kingdom. All authors have repo
contents of this paper to disclose.
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extended in both the LAD and left circumﬂex artery,
we decided to perform V-stenting. A 3.5  12-mm
BVS (LMCA-LAD) and a 3.5  18-mm BVS (LMCA-left
circumﬂex artery) were simultaneously deployed fol-
lowed by ﬁnal kissing-balloon inﬂation. An excellent
ﬁnal angiographic result was achieved (Fig. 1-III).
Post-procedural intravascular ultrasound and opti-
cal coherence tomography exhibited well-apposed
scaffolds with a minimum scaffold area of >6.0 mm2
(Figs. 1 and 2). To date, there are no available data in
the literature regarding the safety and feasibilityFIGURE 1 Coronary Angiography of the Left
Coronary System
(I) Angiogram showing a hazy lesion extending from
distal left main coronary artery (LMCA) into left
anterior descending artery (LAD) ostium (Medina 0.1.1)
(white arrowhead). (II) A 3.5  12-mm bioresorbable
vascular scaffold (BVS) (LMCA to LAD) and a 3.5 
18-mm BVS (LMCA to the left circumﬂex artery [LCx])
were simultaneously deployed (in a kissing fashion at
10 and 8 atm). (III) Final angiogram showing excellent
results. (I–III, left anterior oblique caudal view).
Post-procedural intravascular ultrasound showed
well-apposed scaffolds with a minimal scaffold area of
>6.0 mm2 at the carina site in both the LAD (B) and
LCx (D). IVUS imaging of the distal left main trunk
(LMT) during LAD pullback (A) and LCx pullback (C).
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rted that they have no relationships relevant to the
FIGURE 2 Optical Coherence Tomography Findings Following V-Stenting
V-stenting using a BVS was performed with minimal strut protrusion neocarina (0.8 mm) into the LMCA. Serial 2- and 3-dimensional optical coherence
tomography images obtained from LCx pull-back. A double-strut layer in the left main trunk is shown (white arrows). The neocarina with double-strut layer
of BVS is seen on a 3-dimentional reconstruction (white arrowheads). Abbreviations as in Figure 1.
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e104of V-stenting using BVS for the treatment of LMCA
bifurcation. Unlike the crush or culotte technique,
V-stenting does not deform the BVS struts. Further-
more, it allows access to both branches throughout
the procedure, without the need to rewire. However,
the trade-off for BVS V-stenting is the need for an
8-F guide catheter to allow simultaneous stent
deployment, and the procedure is limited to type
0.1.1 bifurcation lesions according to the Medinaclassiﬁcation (1). The present case illustrates that
V-stenting using BVS is feasible, despite thick
(>150 mm) strut scaffolds, and should be considered
as 1 of the treatment strategies in appropriate lesions.
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